SCHEMBL6764666

SCHEMBL6764666

COC(=O)C1(NC(=O)Cc2ccc(Cl)cc2Cl)CCN(C(C)=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
EPHX2 P34913 3/20 0.43
RECQL P46063 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
THRB P10828 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ANO1 Q5XXA6 1/20 0.40
ENPP2 Q13822 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6766304 0.89 SHMT1 (0.48) KMT2AEPHX2SIGMAR1ALDH1A1ENPP2
SCHEMBL6766446 0.89 KMT2A (0.46) KMT2ARECQLSIGMAR1MEN1ALDH1A1
SCHEMBL29218412 0.86 KMT2A (0.46) KMT2ARECQLMAPTSMN1; SMN2MEN1
SCHEMBL10165687 0.85 KMT2A (0.43) KMT2AEPHX2RECQLSIGMAR1MEN1
SCHEMBL6762268 0.83 SIGMAR1 (0.43) KMT2AEPHX2RECQLSIGMAR1MEN1
SCHEMBL13938960 0.83 RECQL (0.44) KMT2ARECQLMAPTMEN1ALDH1A1
SCHEMBL9046338 0.83 KMT2A (0.43) KMT2AEPHX2RECQLSIGMAR1LMNA
SCHEMBL8905510 0.82 TRPV1 (0.44) KMT2ARECQLSIGMAR1MEN1ALDH1A1
SCHEMBL9045472 0.82 EPHX2 (0.44) KMT2AEPHX2RECQLSIGMAR1LMNA
SCHEMBL6767232 0.81 KMT2A (0.42) KMT2ASIGMAR1MAPTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009999-A1 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides FISCHER REINER (DE) 2004-01-15 US disclosed
US-6555567-B1 2-oxo-3-aryl-4-hydroxy-1-aza-8-thiaspiro(4.5)decane derivatives of given formula; use as arthropodicide or nematicide BAYER AKTIENGESELLSCHAFT (DE) 2003-04-29 US disclosed
US-6479489-B1 AN ARTHROPODICIDAL OR NEMATICIDAL COMPOSITION BAYER AKTIENGESELLSCHAFT (DE) 2002-11-12 US disclosed
US-5981567-A ARTHROPODICIDAL OR NEMATICIDAL COMPOSITION BAYER AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009999-A1 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides DDT, HPD, CAT KMT2A 1459/4885EPHX2 739/4885RECQL 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.